KR100603552B1 - 포피로모나스 긴기발리스 폴리펩티드 및 뉴클레오티드 - Google Patents

포피로모나스 긴기발리스 폴리펩티드 및 뉴클레오티드 Download PDF

Info

Publication number
KR100603552B1
KR100603552B1 KR1020007006386A KR20007006386A KR100603552B1 KR 100603552 B1 KR100603552 B1 KR 100603552B1 KR 1020007006386 A KR1020007006386 A KR 1020007006386A KR 20007006386 A KR20007006386 A KR 20007006386A KR 100603552 B1 KR100603552 B1 KR 100603552B1
Authority
KR
South Korea
Prior art keywords
seq
dna
oligonucleotide primer
gingivalis
primer sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020007006386A
Other languages
English (en)
Korean (ko)
Other versions
KR20010033030A (ko
Inventor
로스부르스카터
바이안죠지
패터슨미첼앤
아기우스캐서린데어스
로텔린다조이
마제츠메이브리기드
혹킹다이아나마가레트
웹엘리자베스앤
Original Assignee
씨에스엘 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP0839A external-priority patent/AUPP083997A0/en
Priority claimed from AUPP1182A external-priority patent/AUPP118297A0/en
Priority claimed from AUPP1546A external-priority patent/AUPP154698A0/en
Priority claimed from AUPP2264A external-priority patent/AUPP226498A0/en
Priority claimed from AUPP2911A external-priority patent/AUPP291198A0/en
Priority claimed from AUPP3128A external-priority patent/AUPP312898A0/en
Priority claimed from AUPP3338A external-priority patent/AUPP333898A0/en
Priority claimed from AUPP3654A external-priority patent/AUPP365498A0/en
Priority claimed from AUPP4917A external-priority patent/AUPP491798A0/en
Priority claimed from AUPP4963A external-priority patent/AUPP496398A0/en
Priority claimed from AUPP5028A external-priority patent/AUPP502898A0/en
Application filed by 씨에스엘 리미티드 filed Critical 씨에스엘 리미티드
Publication of KR20010033030A publication Critical patent/KR20010033030A/ko
Publication of KR100603552B1 publication Critical patent/KR100603552B1/ko
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020007006386A 1997-12-10 1998-12-10 포피로모나스 긴기발리스 폴리펩티드 및 뉴클레오티드 Expired - Fee Related KR100603552B1 (ko)

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
AUPP0839 1997-12-10
AUPP0839A AUPP083997A0 (en) 1997-12-10 1997-12-10 Porphyromonas gingivalis nucleotides
AUPP1182A AUPP118297A0 (en) 1997-12-31 1997-12-31 P. gingivalis sequences
AUPP1182 1997-12-31
AUPP1546A AUPP154698A0 (en) 1998-01-30 1998-01-30 P. gingivalis sequences
AUPP1546 1998-01-30
AUPP2264 1998-03-10
AUPP2264A AUPP226498A0 (en) 1998-03-10 1998-03-10 Porphyromonas gingivalis probes and polypeptides
AUPP2911A AUPP291198A0 (en) 1998-04-09 1998-04-09 P. gingivalis sequences
AUPP2911 1998-04-09
AUPP3128 1998-04-23
AUPP3128A AUPP312898A0 (en) 1998-04-23 1998-04-23 Porphyromonas gingivalis antigens and probes
AUPP3338 1998-05-05
AUPP3338A AUPP333898A0 (en) 1998-05-05 1998-05-05 P. gingivalis sequences
AUPP3654A AUPP365498A0 (en) 1998-05-22 1998-05-22 P. gingivalis sequences
AUPP3654 1998-05-22
AUPP4917 1998-07-29
AUPP4917A AUPP491798A0 (en) 1998-07-29 1998-07-29 P.gingivalis nucleotides and polypeptides
AUPP4963A AUPP496398A0 (en) 1998-07-30 1998-07-30 P.gingivalis polypeptides
AUPP4963 1998-07-30
AUPP5028A AUPP502898A0 (en) 1998-08-04 1998-08-04 P.gingivalis antigens
AUPP5028 1998-08-04
PCT/AU1998/001023 WO1999029870A1 (en) 1997-12-10 1998-12-10 Porphorymonas gingivalis polypeptides and nucleotides

Publications (2)

Publication Number Publication Date
KR20010033030A KR20010033030A (ko) 2001-04-25
KR100603552B1 true KR100603552B1 (ko) 2006-07-20

Family

ID=27581380

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007006386A Expired - Fee Related KR100603552B1 (ko) 1997-12-10 1998-12-10 포피로모나스 긴기발리스 폴리펩티드 및 뉴클레오티드

Country Status (10)

Country Link
EP (10) EP2264176A1 (enExample)
JP (2) JP2001526035A (enExample)
KR (1) KR100603552B1 (enExample)
AT (1) ATE534742T1 (enExample)
AU (1) AU1648799A (enExample)
CA (1) CA2313823A1 (enExample)
DK (2) DK2256205T3 (enExample)
ES (2) ES2419664T3 (enExample)
NZ (1) NZ504811A (enExample)
WO (1) WO1999029870A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4648700A (en) * 1999-04-21 2000-11-02 Daniel Nelson A polypeptide having amidolytic activity for a serpin
US6833262B1 (en) 1999-04-21 2004-12-21 University Of Georgia Research Foundation, Inc. Polypeptide having amidolytic activity for a serpin
AUPQ485999A0 (en) 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
AU2001252042B2 (en) * 2000-04-28 2005-12-01 Csl Limited Porphyromonas gingivalis recombinant proteins and truncations
AUPQ718200A0 (en) * 2000-04-28 2000-05-25 Csl Limited Porphyromonas gingivalis recombinant proteins and truncations
JP2003192616A (ja) * 2001-12-27 2003-07-09 Univ Nihon 歯周病用ｄｎａワクチン
DK1660524T3 (da) * 2003-08-15 2011-05-09 Univ Florida Identifikation af porphyromonas gingivalis virulens polynukleotider til diagnose, behandling, og monitorering af periodontale sygdomme
GB0411150D0 (en) * 2004-05-19 2004-06-23 Queen Mary & Westfield College Vaccine
CA2652957A1 (en) * 2006-06-27 2008-01-03 Oral Health Australia Pty Ltd. Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
AU2013203250B2 (en) * 2007-07-12 2014-11-13 Oral Health Australia Pty Ltd Immunology treatment for biofilms
EP2604692A1 (en) * 2007-07-12 2013-06-19 Oral Health Australia Pty Ltd Immunology treatment for biofilms
CN103357014A (zh) 2007-07-12 2013-10-23 口腔健康澳洲私人有限公司 生物膜治疗
RU2012107993A (ru) * 2009-08-02 2013-09-10 Санофи Пастер Лимитид Полипептиды porhyromonas gingivalis
TWI542695B (zh) * 2010-12-15 2016-07-21 日星股份有限公司 牙周病原菌血漿或血清抗體價檢查套組
JP6310631B2 (ja) * 2011-10-18 2018-04-11 サンスター株式会社 歯周病原菌血漿または血清抗体価検査キット
EP3519429B1 (en) * 2016-09-29 2021-11-10 Meharry Medical College Peptides derived from s. cristatus arginine deiminase as bacterial inhibitors
CN111172177B (zh) * 2019-07-30 2023-08-08 镇江市江澜绿洲生物技术有限公司 cra4S1基因及其编码的蛋白和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047238A (en) 1983-06-15 1991-09-10 American Home Products Corporation Adjuvants for vaccines
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5830710A (en) * 1988-09-08 1998-11-03 University Of Florida Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
US5643781A (en) * 1992-12-29 1997-07-01 Doheny Eye Institute DNA encoding protocadherin-42
US5798224A (en) * 1992-12-29 1998-08-25 Doheny Eye Institute Nucleic acids encoding protocadherin
US5523390A (en) * 1993-09-10 1996-06-04 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
US5475097A (en) 1993-10-21 1995-12-12 University Of Georgia Research Foundation, Inc. Lysine-specific Porphyromonas gingivalis proteinase
AU7822394A (en) * 1993-10-08 1995-05-04 Lion Corporation Fimbrillin protein of porphyromonas gingivalis
AUPN015794A0 (en) 1994-12-20 1995-01-19 Csl Limited Variants of human papilloma virus antigens
AUPN627595A0 (en) * 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
AU742668B2 (en) * 1996-03-22 2002-01-10 Morehouse School Of Medicine Immunogenic compositions comprising porphyromonas gingivalis peptides and methods
AUPN901296A0 (en) * 1996-03-29 1996-04-26 University Of Melbourne, The Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
AUPO652897A0 (en) * 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis

Also Published As

Publication number Publication date
KR20010033030A (ko) 2001-04-25
NZ504811A (en) 2003-10-31
EP2283852A3 (en) 2011-05-04
EP1037999A1 (en) 2000-09-27
EP2283853A3 (en) 2011-05-11
ATE534742T1 (de) 2011-12-15
JP2001526035A (ja) 2001-12-18
ES2419664T3 (es) 2013-08-21
EP1908772A2 (en) 2008-04-09
EP1681350A3 (en) 2007-07-18
EP2283852A2 (en) 2011-02-16
EP2283855A2 (en) 2011-02-16
EP2256205A1 (en) 2010-12-01
AU1648799A (en) 1999-06-28
EP2283854A2 (en) 2011-02-16
DK1908772T3 (da) 2012-03-19
EP2283855A3 (en) 2011-05-04
DK2256205T3 (da) 2013-07-08
ES2377751T3 (es) 2012-03-30
WO1999029870A1 (en) 1999-06-17
EP2264176A1 (en) 2010-12-22
CA2313823A1 (en) 1999-06-17
EP1908772A3 (en) 2008-12-03
EP1681350A2 (en) 2006-07-19
EP2256204A1 (en) 2010-12-01
EP2256205B1 (en) 2013-04-03
EP2283853A2 (en) 2011-02-16
EP1908772B1 (en) 2011-11-23
JP2009136300A (ja) 2009-06-25
EP1037999A4 (en) 2005-03-23
EP2283854A3 (en) 2011-04-06
JP5349070B2 (ja) 2013-11-20

Similar Documents

Publication Publication Date Title
AU2016278069B2 (en) Compositions comprising bacterial strains
KR101914245B1 (ko) 박테리아성 균주를 함유한 조성물
AU2016278066B2 (en) Compositions comprising bacterial strains
AU2016278067B2 (en) Compositions comprising bacterial strains
KR101942955B1 (ko) 면역 조정
KR102607213B1 (ko) 암모니아-산화 니트로소모나스 유트로파 균주 d23
AU2016357553A1 (en) Compositions comprising bacterial strains
AU7280598A (en) Enterococcus faecalis polynucleotides and polypeptides
KR100603552B1 (ko) 포피로모나스 긴기발리스 폴리펩티드 및 뉴클레오티드
KR102521444B1 (ko) 세균 균주를 포함하는 조성물
KR102531695B1 (ko) 프로바이오틱으로서 사용하기 위한 락토바실러스, 및 프로바이오틱을 비롯한 제제에 대한 면역 반응을 평가하기 위해 사용되는 혈액 세포 집단
KR102411381B1 (ko) 서팩틴 및 효소 생산능이 우수한 바실러스 서브틸리스 균주 및 이의 용도
KR20200019882A (ko) 세균 균주를 포함하는 조성물
KR20210080303A (ko) 단쇄 지방산을 생산하는 균주, 항생제 내성 병원균에 대한 항균 활성 균주 및 이를 포함하는 항균용 조성물
KR20200038970A (ko) 박테리아 균주를 포함하는 조성물
KR20220135669A (ko) 서팩틴을 생산하는 신규한 바실러스 서브틸리스 균주 및 이의 용도
KR20190059562A (ko) γPGA 활성을 가지는 신규 고초균 및 이의 용도
AU2018205072B2 (en) Immune modulation
KR20190057791A (ko) 단백질 분해활성을 가지는 신규한 고초균 및 이의 용도
TW202310861A (zh) 包含細菌菌株之組合物
AU3796099A (en) Assays using nucleic acid and amino acid sequences relating to helicobacter pylori
CZ388697A3 (cs) Sekvence nukleových kyselin a aminokyselin vztahujících se k helicobacter pylori pro diagnostiku a terapii

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20130628

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

FPAY Annual fee payment

Payment date: 20140618

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20150714

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20150714

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000